| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 07/22/1993 | WO1993013777A1 Method of using m1-selective antimuscarinic pyridobenzodiazepinones in axial myopia therapy |
| 07/22/1993 | WO1993013771A1 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
| 07/22/1993 | CA2127251A1 Heterocyclic compounds and their preparation and use |
| 07/22/1993 | CA2126687A1 Substituted phosphinic acid-containing peptidyl derivatives as antidegenerative agents |
| 07/22/1993 | CA2087510A1 Method of using m1-selective antimuscarinic pyridobenzodiazepiones in axial myopia therapy |
| 07/21/1993 | EP0551848A1 Ophthalmic pharmaceutical composition containing N-acetyl-cysteine and polyvinylalcohol |
| 07/21/1993 | EP0551626A1 Thermoreversible gel as a liquid pharmaceutical carrier for a galenic formulation |
| 07/20/1993 | CA1320498C2 Methods and compositions for inhibiting lipoxygenase |
| 07/20/1993 | CA1320493C Substituted thieno (2,3-.beta.) thiophene-2-sulfonamides as antiglauc oma agents |
| 07/20/1993 | CA1320487C Substituted thieno[2,3-.beta.]thiophene-2-sulfonamides as antiglaucoma agents |
| 07/14/1993 | EP0557290A4 Treatment of aids dementia, myelopathy, peripheral neuropathy, and vision loss. |
| 07/14/1993 | EP0551219A1 Pyridylsulfonylurea, processes for their preparation and pharmaceutical compositions containing them |
| 07/14/1993 | EP0550444A1 Substituted naphthoxazines useful as dopaminergics |
| 07/14/1993 | EP0362321B1 Ophthalmic suspensions |
| 07/13/1993 | US5227404 Pharmaceutical composition for the treatment of glaucomatous optic neuropathy |
| 07/13/1993 | US5227401 Ethynyl alanine amino diol compounds for treatment of hypertension |
| 07/13/1993 | CA1320131C Aqueous pharmaceutical preparation containing 11.beta.-hydroxy steroids |
| 07/08/1993 | WO1993013092A1 Imidazolidinedione derivatives |
| 07/08/1993 | WO1993013083A1 Oxadiazole derivatives having acetylcholinesterase-inhibitory and muscarinic agonist activity |
| 07/08/1993 | WO1993012808A1 A method for treating kaposi's sarcoma and blocking or inhibiting vascular permeability |
| 07/08/1993 | WO1993012796A1 Use of renin inhibitors for the treatment of glaucoma |
| 07/08/1993 | WO1993012786A1 Indolinone derivatives |
| 07/08/1993 | WO1993012754A2 Tertiary and secondary amines as alpha-2 antagonists and serotonin uptake inhibitors |
| 07/08/1993 | CA2126976A1 Oxadiazole derivatives having acetylcholinesterase-inhibitory and muscarinic agonist activity |
| 07/08/1993 | CA2126211A1 Use of renin inhibitors for the treatment of glaucoma |
| 07/08/1993 | CA2126108A1 A method for treating kaposi's sarcoma and blocking or inhibiting vascular permeability |
| 07/08/1993 | CA2125392A1 Tertiary and secondary amines as alpha-2-antagonists and serotonin uptake inhibitors |
| 07/07/1993 | EP0550008A2 Use of N-acyl derivatives of aminoalcohols with polycarboxylic acids for the manufacture of a medicament for the treatment of pathologies relating to mast cells |
| 07/07/1993 | EP0550006A2 Use of N-acyl derivatives of aminoalcohols for the manufacture of a medicament for the treatment of pathologies involving mast cells |
| 07/07/1993 | EP0549600A1 5-trifluoroacylamino-2-aryl oxazoles |
| 07/07/1993 | CA2086698A1 Pyridylsulfonylurea derivatives, processes for their preparation and pharmaceutical compositions containing them |
| 07/06/1993 | US5225420 Use of tetrahydrothienopyridine derivatives as angiogenesis inhibitors |
| 07/01/1993 | CA2086442A1 N-acyl derivatives of aminoalcohols active as local autocoidis and useful in the therapy of autoimmune processes |
| 07/01/1993 | CA2086441A1 N-acyl derivatives of aminoalcohols with polycarboxylic acids able to modulate mast cells in inflammatory processes having meuroimmunogenic origin |
| 06/30/1993 | EP0548254A1 6- or 7- (2-IMINO-2-IMIDAZOLIDINE)-1,4-BENZOXAZINES AS ALPHA ADRENERGIC AGENTS |
| 06/30/1993 | EP0528875A4 Enzymatic disinsertion of vitreous body |
| 06/29/1993 | US5223499 6-amino substituted imidazo[4,5-bipyridines as angiotensin II antagonists |
| 06/24/1993 | WO1993012108A1 Imidazolyl or imidazoylalkyl substituted with a four or five membered nitrogen containing heterocyclic ring |
| 06/24/1993 | WO1993012107A1 Imidazoylalkyl substituted with a six membered nitrogen containing heterocyclic ring |
| 06/24/1993 | WO1993012095A1 Quinazolinone antianginal agents |
| 06/24/1993 | WO1993012085A1 Isatin derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same |
| 06/24/1993 | WO1993011794A1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| 06/24/1993 | CA2124826A1 Isatin derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same |
| 06/23/1993 | EP0547558A1 Use of aminoguanidine for the manufacture of a medicament for inhibiting nitric oxide formation |
| 06/23/1993 | EP0348527B1 Antiallergic eye drop |
| 06/23/1993 | CN1021325C Process for preparing ethynylphenyl-containing retinoic acid derivatives |
| 06/22/1993 | US5221678 Cardiovascular disorders, antiinflammatory agents, antiallergens |
| 06/22/1993 | CA1319322C Azelastine-containing medicaments for application in the nose and/or eye |
| 06/20/1993 | CA2085690A1 Thermoreversible gel as a liquid pharmaceutical carrier for a galenic formulation |
| 06/17/1993 | CA2085399A1 Method for inhibiting nitric oxide formation |
| 06/16/1993 | EP0546728A2 Physiological tear compositions and methods for their preparation |
| 06/16/1993 | EP0546449A2 Benzofuranderivatives as angiotensin II antagonists |
| 06/16/1993 | EP0308500B1 Human somatomedin carrier protein subunits and process for producing them |
| 06/16/1993 | CN1073174A Heterocyclic derivatives |
| 06/16/1993 | CN1073166A Derivative of hydroximic acid |
| 06/15/1993 | US5220017 Gastrointestinal, central nervous system disorders |
| 06/15/1993 | US5219849 Substituted pyrazines, pyrimidines and pyridazines for use in the treatment of glaucoma |
| 06/15/1993 | CA1319099C Atriopeptins, guanylate cyclase activators, and phosphodiesterase inhibitors as treatment for glaucoma, hydrocephalus and cerebral edema (cranial fluid volume dysfunction) |
| 06/10/1993 | WO1993011105A1 Leukotriene-b4 derivatives, process for preparing the same and medicaments |
| 06/10/1993 | WO1993010809A1 Fibronectin-containing ophthalmic solution, method of manufacture of an ophthalmic solution, method of preserving an ophthalmic solution, and methods of treatment of ophthalmic wounds |
| 06/10/1993 | WO1993010791A1 Use of a known chemical compound for the production of a pharmaceutical composition for topical application |
| 06/10/1993 | CA2124852A1 Use of a known chemical compound for the production of a pharmaceutical composition for topical application |
| 06/10/1993 | CA2122992A1 Leukotriene-b derivatives, process for preparing the same and medicaments |
| 06/10/1993 | CA2084736A1 Benzofuranes |
| 06/09/1993 | EP0544899A1 Prostaglandins. |
| 06/09/1993 | EP0544779A1 Heterocyclic compounds and their preparation and use |
| 06/09/1993 | EP0544756A1 1,2,5,6-tetrahydro-1-methylpyridines, their preparation and use |
| 06/08/1993 | US5218115 Cholecystokinin antagonists |
| 06/08/1993 | US5218114 Cholecystokinin antagonists |
| 06/08/1993 | US5217976 Hypotensive agents, congestive heart failure |
| 06/02/1993 | EP0544620A1 Macrocyclic lactams as inhibitors of atrial natriuretic factors (ANF)-degrading neutral endopeptidase (NEP) |
| 06/02/1993 | EP0543811A1 Topical treatment of blepharitis |
| 06/01/1993 | US5216020 Substituted 4,5-dihydrothieno(2,3-b)thiophene-2-sulfonamides and 6,6-dioxides thereof |
| 06/01/1993 | CA1318594C Beta blockers for the treatment of the progression of axial myopia in children |
| 05/28/1993 | CA2083232A1 Fibronectin-containing ophthalmic solution, method of manufacture of an ophthalmic solution, method of preserving an ophthalmic solution, and methods of treatment of ophthalmic wounds |
| 05/27/1993 | WO1993010141A2 Angiostatic steroids |
| 05/27/1993 | CA2425846A1 Angiostatic steroids |
| 05/27/1993 | CA2083622A1 Certain macrocyclic lactam derivatives |
| 05/26/1993 | EP0543497A1 Tricyclic thienothiopyrans as antiglancoma agents |
| 05/26/1993 | EP0543491A2 Angiotensin II antagonists having a substituted 1,3-benzodioxolering or 1,3-benzodithiolering |
| 05/26/1993 | EP0543201A2 Alkoxylated phenyl and coumarin derivatives, their production and use for the manufacture of medicaments |
| 05/26/1993 | EP0228415B1 Increasing aqueous humor outflow |
| 05/26/1993 | CN1072408A Process for preparing 13, 14-dihydro-15(r)-17-phenyl-18'19'20-trinor-pgf 2 alpha esters |
| 05/19/1993 | EP0542554A1 Substituted N-biphenylyl lactams |
| 05/19/1993 | EP0541705A1 Substituted 1h-imidazol-5-yl]alkanoic acids |
| 05/18/1993 | US5212185 Piperidinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension |
| 05/18/1993 | US5211657 Laminin a chain deduced amino acid sequence, expression vectors and active synthetic peptides |
| 05/18/1993 | CA1317944C 2-amino-4-morpholino-6-propyl-1,3,5-triazines |
| 05/18/1993 | CA1317939C ¬(bicyclic heterocyclyl)methyl and -hetero| substituted hexahydro-1h-azepines and pyrrolidines |
| 05/14/1993 | CA2082787A1 Substituted n-biphenylyl lactams |
| 05/13/1993 | WO1993009090A1 Hydroxamic acid derivative |
| 05/13/1993 | WO1993008826A1 Treating retinal neuronal disorders by the application of insulin-like growth factors and analogs |
| 05/13/1993 | WO1993008816A1 Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof |
| 05/13/1993 | WO1993008815A1 Pharmaceutical dipeptide compositions and methods of use thereof |
| 05/13/1993 | CA2122046A1 Hydroxamic acid derivative |
| 05/13/1993 | CA2122024A1 Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof |
| 05/12/1993 | EP0540747A1 Medicine for intraocular operation |
| 05/12/1993 | EP0540576A1 Psychoactive drug and treatment |
| 05/12/1993 | EP0525054A4 Modified heparin binding growth factors |
| 05/11/1993 | US5210211 4-(1h-pyrrol-1-yl) imidazoles with angiotension ii antagonist activity |